# Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

> **NCT00899613** · — · UNKNOWN · sponsor: **University Hospital, Caen** · enrollment: 270 (estimated)

## Conditions studied

- Malignant Mesothelioma
- Metastatic Cancer

## Interventions

- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** study of high risk factors

## Key facts

- **NCT ID:** NCT00899613
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** 2010-01
- **Final completion:** —
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2009-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00899613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00899613, "Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00899613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*